Driving Drug Development with CRISPR/Cas9
Within the past decade, CRISPR/Cas9 gene editing of mammalian cells has become common practice, but does it hold the key to unlocking future of therapeutic development? Join Dr. David Fischer and our panel for a detailed look at the advantages and applications of this Nobel Prize-winning technology.
Acknowledgements:
Hosted by: Gina Mullane
Narrated by: Chris Garcia
Special thanks to:
Dr. David Fischer
The podcast Vital Science is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.